Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow biopsy morbidity and mortality.

Barbara J Bain1

  • 1Department of Haematology, St Mary's Hospital Campus, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Praed Street, London W2 1NY, UK. b.bain@ic.ac.uk

British Journal of Haematology
|June 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral Blood Lymphocytosis Reflecting an Underlying Thymoma.

American journal of hematology·2026
Same author

Striking Bone Marrow Plasmacytosis Resulting From Visceral Leishmaniasis.

American journal of hematology·2026
Same author

Compound Heterozygosity for Hemoglobin S and Hemoglobin LuLu Island.

American journal of hematology·2026
Same author

Hemophagocytic Macrophages in the Peripheral Blood of a Critically Ill Patient With COVID-19 and RSV Infection.

American journal of hematology·2026
Same author

Can We Really Believe This Platelet Count?

American journal of hematology·2025
Same author

MDS/MPN With SF3B1 Mutation and Thrombocytosis but Without Ring Sideroblasts.

American journal of hematology·2025

Bone marrow biopsy is generally safe, with rare serious adverse events like hemorrhage. Risk factors for bleeding include myeloproliferative disorders and aspirin use.

Area of Science:

  • Hematology
  • Medical Procedures
  • Patient Safety

Background:

  • Bone marrow biopsy is a critical diagnostic tool in hematology.
  • Understanding the safety profile of this procedure is essential for clinical practice.

Purpose of the Study:

  • To assess the incidence and nature of adverse events following bone marrow biopsy.
  • To identify risk factors associated with serious complications.

Main Methods:

  • A postal survey was conducted among members of the British Society of Haematology.
  • Data were collected on adverse events occurring between 1995 and 2001.

Main Results:

  • 26 adverse events were reported from an estimated 54,890 biopsies.

Related Experiment Videos

  • Hemorrhage was the most frequent and serious event (14 cases), leading to one death.
  • Risk factors for hemorrhage included myeloproliferative disorders and aspirin therapy.

    • Conclusions:

    • Bone marrow biopsy carries a low risk of serious adverse events.
    • Hemorrhage is the primary concern, particularly in patients with specific risk factors.
    • Awareness of these risk factors can guide preventative strategies.